Insulin as a primary autoantigen for type 1A diabetes.

作者: J. M. Jasinski , G. S. Eisenbarth

DOI: 10.1080/17402520500078204

关键词:

摘要: Type 1A diabetes mellitus is caused by specific and progressive autoimmune destruction of the beta cells in islets Langerhans whereas other cell types islet (alpha, delta, PP) are spared. The autoantigens may be divided into subgroups based on their tissue distributions: Beta-cell-specific antigens like insulin, insulin derivatives, IGRP (Islet-specific Glucose-6-phosphatase catalytic subunit Related Peptide); neurendocrine such as carboxypeptidase H, insulinoma-associated antigen (IA-2), glutamic acid decarboxylase (GAD65), E; those expressed ubiquitously heat shock protein 60 (a putative autoantigen for type 1 diabetes). This review will focus specifically a primary autoantigen, an essential target disease, mellitus. In particular, immunization with peptide B:9-23 can used to induce autoantibodies animal models or prevent diabetes. Genetic manipulation 2 genes reciprocally alters development NOD mouse, gene polymorphisms important determinants childhood We pursuing hypothesis that diabetes, thus pathogenesis disease relates recognition one more peptides.

参考文章(59)
Daniel J McCarty, Paul Z Zimmet, Ian R Mackay, Merrill J Rowley, Robert Turner, Crucial points at diagnosis. Type 2 diabetes or slow type 1 diabetes. Diabetes Care. ,vol. 22, pp. 59- 64 ,(1999)
Jorge Daaboul, Desmond Schatz, Overview of prevention and intervention trials for type 1 diabetes. Reviews in Endocrine & Metabolic Disorders. ,vol. 4, pp. 317- 323 ,(2003) , 10.1023/A:1027308310837
Patricia M Graves, Harley A Rotbart, William A Nix, Mark A Pallansch, Henry A Erlich, Jill M Norris, Michelle Hoffman, George S Eisenbarth, Marian Rewers, Prospective study of enteroviral infections and development of beta-cell autoimmunity Diabetes Research and Clinical Practice. ,vol. 59, pp. 51- 61 ,(2003) , 10.1016/S0168-8227(02)00198-5
Philippe Halbout, Jean-Paul Briand, Chantal Bécourt, Sylviane Muller, Christian Boitard, T Cell Response to Preproinsulin I and II in the Nonobese Diabetic Mouse The Journal of Immunology. ,vol. 169, pp. 2436- 2443 ,(2002) , 10.4049/JIMMUNOL.169.5.2436
George S Eisenbarth, Type 1 diabetes: molecular, cellular and clinical immunology. Advances in Experimental Medicine and Biology. ,vol. 552, pp. 306- 310 ,(2004)
David V. Serreze, Roland Michael Tisch, Scott D. Richard, Edward H. Leiter, Harold D. Chapman, Sara A. Fleming, B Lymphocytes Are Critical Antigen-Presenting Cells for the Initiation of T Cell-Mediated Autoimmune Diabetes in Nonobese Diabetic Mice Journal of Immunology. ,vol. 161, pp. 3912- 3918 ,(1998)
Béatrice Faideau, Jean-Paul Briand, Chantal Lotton, Isabelle Tardivel, Philippe Halbout, Jacques Jami, John F. Elliott, Patricia Krief, Sylviane Muller, Christian Boitard, Jean-Claude Carel, Expression of Preproinsulin-2 Gene Shapes the Immune Response to Preproinsulin in Normal Mice The Journal of Immunology. ,vol. 172, pp. 25- 33 ,(2004) , 10.4049/JIMMUNOL.172.1.25
F. Susan Wong, Jaana Karttunen, Caroline Dumont, Li Wen, Irene Visintin, Ingrid M. Pilip, Nilabh Shastri, Eric G. Pamer, Charles A. Janeway, Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library. Nature Medicine. ,vol. 5, pp. 1026- 1031 ,(1999) , 10.1038/12465
Stephan Martin, Dorothea Wolf-Eichbaum, Gaby Duinkerken, Werner A. Scherbaum, Hubert Kolb, Jeroen G. Noordzij, Bart O. Roep, Development of type 1 diabetes despite severe hereditary B-cell deficiency. The New England Journal of Medicine. ,vol. 345, pp. 1036- 1040 ,(2001) , 10.1056/NEJMOA010465